Dr. Langanani Mbodi

Langanani Mbodi is a clinician–scientist in oncology whose work bridges gynecologic oncology, molecular cancer research, and precision medicine. Affiliated with South African academic and tertiary hospital settings, this researcher contributes to both clinical audits and translational cancer studies, with a focus on improving outcomes in resource-constrained environments.

The publication record reflects strong emphasis on chemotherapy resistance in cervical, breast, colorectal, and melanoma cancers. Research explores nanotechnology-based drug delivery, phytochemical therapeutics such as Tulbaghia violacea in triple-negative breast cancer, and molecular mechanisms underlying metastasis and treatment failure. Work on gynecological cancer mortality and cervical screening adherence highlights commitment to public health and evidence-based clinical practice.

Additional contributions examine the integration of metabolomics, artificial intelligence, and gut microbiome science into precision oncology. These interdisciplinary efforts demonstrate expertise in translational oncology, biomarker discovery, and innovative therapeutic strategies aimed at personalized cancer care, positioning Mbodi as an emerging voice in precision cancer research.